Evidence map›Paper›PMID 40788043›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026

Residential Proximity to NPL Superfund Sites and High Particulate Matter Exposure Is Associated with Increased Likelihood of Triple-Negative Breast Cancer.

Peter A Borowsky, Lauren Nahodyl, Stella Sable, Maria A Sierra, Stephanie Gonzalez, Emma L Herbach, Nancy S Elliott, Aristeidis G Telonis, Neha Goel, Erin N Kobetz

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peter A BorowskyDivision of Surgical Oncology, Dewitt Daughtry Department of Surgery, University of Miami, Miami, Florida.ORCID 0000-0002-7185-2417
Lauren NahodylClinical Translational Science Institute, University of Miami, Miami, Florida.ORCID 0009-0007-1302-1547
Stella SableUniversity of Miami Miller School of Medicine, Miami, Florida.ORCID 0009-0004-2602-960X
Maria A SierraDivision of Surgical Oncology, Dewitt Daughtry Department of Surgery, University of Miami, Miami, Florida.ORCID 0009-0005-5216-5071
Stephanie GonzalezUniversity of Miami Miller School of Medicine, Miami, Florida.ORCID 0009-0003-6979-3889
Emma L HerbachSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0003-4090-9174
Nancy S ElliottSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0002-4181-7338
Aristeidis G TelonisSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0003-1575-2769
Neha GoelDivision of Surgical Oncology, Dewitt Daughtry Department of Surgery, University of Miami, Miami, Florida.ORCID 0000-0003-0357-4109
Erin N KobetzSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.ORCID 0000-0001-9215-5525

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Tumor Biology Research ProgramP30CA240139 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephen D. Nimer · 2019 to 2026
$24.1M
Miami Clinical and Translational Science InstituteUM1TR004556 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Olveen Carrasquillo, ERIN N KOBETZ · 2023 to 2026
$16.0M
UM Calabresi Clinical Oncology Research Career Development AwardK12CA226330 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Alan Pollack · 2018 to 2026
$5.1M
Training to Reduce Burden across the Cancer Control Continuum (TRACC)T32CA251064 · NCI · UNIVERSITY OF MIAMI CORAL GABLES · PI ERIN N KOBETZ, Frank J Penedo · 2020 to 2026
$3.2M
American Society of Clinical Oncology (ASCO)American Surgical Association Foundation (ASAF)Breast Cancer Research Foundation (BCRF)National Cancer Institute (NCI) 5T32CA251064-04National Cancer Institute (NCI) 5T32CA251064-05National Cancer Institute (NCI) K12CA226330National Cancer Institute (NCI) T32CA251064NCATS NIH HHS UM1 TR004556NCI NIH HHS K12 CA226330NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA240139NCI NIH HHS T32 CA251064Sylvester Comprehensive Cancer Center, University of Miami Health Systems (Sylvester Comprehensive Cancer Center) 1P30CA240139-01Sylvester Comprehensive Cancer Center, University of Miami Health Systems (Sylvester Comprehensive Cancer Center) 1UM1TR004556-01Sylvester Comprehensive Cancer Center, University of Miami Health Systems (Sylvester Comprehensive Cancer Center) 5P30240139-02
6 · The paper itself

Abstract

backgroundTriple-negative breast cancer (TNBC) is associated with disadvantaged neighborhoods and at-risk groups. Less is known about how environmental exposures drive TNBC. This study assesses associations of Superfund (SF) site and poor air quality exposure with TNBC.

methodsA retrospective review was performed for patients with stage I to IV breast cancer treated between 2005 and 2018. SF locations were geocoded and compared with patient addresses to determine proximity. Proximity was defined as <4 miles to the nearest site. Daily maximum particulate matter (PM2.5) measurements were sourced and merged with addresses; high exposure was defined as >35 μg/m3. Multilevel regression analyses controlling for demographic and clinical factors were performed to assess associations among SF proximity, PM2.5 exposure, and likelihood of TNBC compared with other breast cancer subtypes.

resultsA total of 3,181 patients with a mean age 56 ± 12 years were included. Eighty percent (n = 2,551) were White, and 20% (n = 630) were Black. Nineteen percent (n = 618) had TNBC. Forty-four percent (n = 1,410) lived close (<4 miles) to SF sites. Two percent (n = 56) had "high" PM2.5 exposure. On multilevel analysis, patients living "close" to SF (OR = 1.33; 95% confidence interval, 1.05-1.67; P = 0.015) and with "high" PM2.5 exposure (OR = 2.09; 95% confidence interval, 1.04-4.02; P = 0.039) had higher TNBC likelihood.

conclusionsLiving near SF sites and having "high" PM2.5 exposure were associated with higher TNBC likelihood. These findings merit further inquiry on the role of environmental contaminants on breast cancer subtype development. IMPACT: Residential exposure to SF sites and high PM2.5 levels may drive aggressive breast cancer biology, including TNBC. See related In the Spotlight, p. 7.

Indexed as

Air PollutionEnvironmental ExposureParticulate MatterTriple Negative Breast NeoplasmsAdultAgedFemaleHumansMiddle AgedRetrospective StudiesRisk FactorsParticulate Matter

Identifiers

PMID40788043
PMCPMC12643579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.